Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
JAK-STAT|September 24, 2013
STAT3 signaling in pulmonary arterial hypertensionRoxane Paulin, Jolyane Meloche, Sébastien BonnetCurrent Vascular Pharmacology|May 30, 2013
Therapeutic Potential of microRNA Modulation in Pulmonary Arterial HypertensionJolyane Meloche, Roxane Paulin, Steeve Provencher, et al.Handbook of Experimental Pharmacology|October 5, 2013
Anti-inflammatory and immunosuppressive agents in PAHJolyane Meloche, Sébastien Renard, Steeve Provencher, et al.The Canadian Journal of Cardiology|January 30, 2015
Adaptation and remodelling of the pulmonary circulation in pulmonary hypertensionMylène Vaillancourt, Grégoire Ruffenach, Jolyane Meloche, et al.International Journal of Molecular Sciences|June 25, 2016
DNA Damage and Pulmonary HypertensionBenoît Ranchoux, Jolyane Meloche, Roxane Paulin, et al.Drug Discovery Today|June 3, 2014
miRNAs in PAH: biomarker, therapeutic target or both?Jolyane Meloche, Aude Pflieger, Mylène Vaillancourt, et al.Cellular and Molecular Life Sciences : CMLS|March 27, 2012
Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertensionMarjorie Barrier, Jolyane Meloche, Maria Helena Jacob, et al.American Journal of Physiology. Heart and Circulatory Physiology|September 6, 2011
Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertensionRoxane Paulin, Jolyane Meloche, Maria Helena Jacob, et al.Pulmonary Circulation|September 10, 2013
Signal transduction in the development of pulmonary arterial hypertensionSimon Malenfant, Anne-Sophie Neyron, Roxane Paulin, et al.American Journal of Physiology. Heart and Circulatory Physiology|August 17, 2010
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseasesCaroline M Lambert, Mélanie Roy, Jolyane Meloche, et al.Pageof 3